BioTAB Healthcare’s Post

Powerful statements from HT4M talk at The Future of Medicaid Innovation 2024, during JP Morgan Healthcare conference: "Every system is designed to get the outcome you get" - Darshan Sanghavi, Program Manager, Advanced Research Projects for Health "It's not about doing things differently, it is about doing different things - Quita Highsmith, Vice President & Chief Diversity, Genentech Letting these sink in, these ideas apply to any organization, initiative, situation for which one wants improved outcomes #Innovation #dodifferntthings

I was able to attend SmithRx's virtual presentation on The Cost Based Future of PBMs, and I have to say, they did a great job providing clarity on the complex challenges we face. Their analysis of the Big 3 PBMs' tactics was informative and really underscored some of the key conversations we need to be having in our industry. This is the driving force at LucyRx: a shared commitment to doing the right things and providing customer-focused solutions in pharmacy benefit management. It's a breath of fresh air seeing others champion these worthy values, as it shows to us we can change things shoulder to shoulder. In an industry where we should be working to give patients access to affordable health care, the system is working in an opposite manner—the Big 3 PBMs are actually driving higher costs and members and plan sponsors foot the bill. That's just wrong. Thanks to Jake Frenz, Sam Slaughter, and the rest of SmithRx's team for sharing such an insightful, and well-prepared presentation. Follow LucyRx for even more thought-provoking, bar-raising conversations in the innovation of pharmacy service. #PharmacyBenefits #HealthcareInnovation #IndustryLeadership #LucyRx

Three words that summarise Baxter Saalfeld: Safe, Engaging, and Inclusive.   In Saalfeld, we are transforming healthcare and expanding our community of 450 colleagues, and we want you to join us.   Be a part of something big; build something that matters.   #SavingandSustainingLives #ThisIsWhere #BaxterSaalfeld

🌟 Thrilled to unveil a stellar Panel discussion at the #Fierce50Gala! 🌟 Join us for an engaging panel discussion ( Panel Discussion: Beyond the Status Quo: Insights from the Fierce 50) featuring a selection of this year's esteemed Fierce 50 honorees, each involved in reshaping healthcare and biopharma. They'll explain why settling for the status quo isn't an option and dive into the challenges and bright spots in these industries. They'll also share the valuable lessons they've learned from their experiences and discuss the biggest opportunities in the year ahead. Save the date - December 5, 2023, and join us at the Edison Ballroom in New York City for this extraordinary discussion. REGISTER NOW➡️: https://ow.ly/U6J250Q4LbZ 🗣️ Moderated by the exceptional Ayla Ellison, this session will feature insights and expertise from some of the most influential figures in healthcare and life sciences: 🔹 Jesse Ehrenfeld MD MPH - American Medical Association 🔹 Melinda Richter - Johnson & Johnson Innovation - JLABS. 🔹 Joseph Betancourt - The Commonwealth Fund. 🔹 Josh Trautwein - About Fresh. 🔹 James R. Downing, M.D. - St. Jude Children's Research Hospital. This powerhouse panel will explore groundbreaking ideas and game-changing strategies that will shape the future of healthcare and life sciences. Don't miss this unique opportunity to gain insights from the Fierce 50 leaders who are redefining the industry. See you there! 🗓️ #Fierce50Gala #Fierce50 #WeAreFierce #LifeSciences #Healthcare #Panel #Innovation #LifeSciences #ThoughtLeadership #NetworkingOpportunity #GalaEvent

During Q1 of this year, a recognition was granted to those countries that stood out for making a big difference in some categories I feel very honored and happy to obtain this reward at the International level. Of course, together with this great team 😁🏅🏆 Without a doubt, make passion be the reflection of the things we do. 💙🤓📚 Let's continue creating evidence for the benefit of patients! 💪🏼 #evidencegeneration #cardiorenal #ckd #Hearthfailure #earlydiagnosis

Our advancements aren’t frivolous “features” that are rebranding efforts of old technologies or a different “spin” on tonic waveforms. These are meaningful clinical advancements that are proven to help patients live and interact with their Abbott technology. We have a history of this: -The First wireless trial system. Do you remember when trial EPGs were attached to patient controllers via wires? We changed that game. -BurstDR- the only proprietary waveform with level 1a evidence. The only waveform that is proven to modulate both physical and emotional pain. Are you familiar with the anterior cingulate cortex of the brain? This is extremely important in treating chronic pain patients. -Proclaim XR - the first long term, non-rechargeable IPG of up to 10 years. -DRG - the clinical superior therapy for CRPS indications -Apple Technology - consumer familiar controllers in which our patients receive an iPhone. The list goes on. While I’m super proud and thankful for the awards mentioned below, I’m not surprised either. Can’t wait to see what’s next! #abbottproud #patientcentric

Last month, I had the privilege of moderating the "Health Innovation & Incubator Roundtable Discussion" at the AGHE Annual Summit in #Davos. I was joined by a group of panelists who are truly changing the way we think and solve problems in healthcare systems around the world. The outcomes of the work these individuals do don’t just promise improved care, but more equitable care too. In our discussion, the panelists shared their experiences driving healthcare incubators across diverse markets. Each of their stories reiterated that innovation lies at the heart of healthcare advancement and #healthequity, and navigating the intricacies of international healthcare systems is a formidable task. - Market-Centric Innovation: Innovations must prioritize #patients while considering regulatory and delivery contexts - Inclusive Procurement: Promoting aid procurement that considers local development allows for #sustainability and empowers local entrepreneurs to effectively address challenges - Fast-Track Processes: There is major disparity in the speed of regulatory processes across regions and we must advocate for a reduction in global barriers to ensure #equitableaccess to life-saving drugs - Cross-Regional Innovation Adoption: Investigating the adoption of innovations from the global south in the global north can ensure that cost-effective solutions with widespread applicability aren't impeded by preconceived notions but are instead embraced for their potential value in #healthcare. At Acquis, we help life science companies, healthcare systems, and insurance providers drive innovation in healthcare, all with the patient in mind. Discover more about Acquis Consulting Group at www.acquisconsulting.com. Thanks to everyone who joined the discussion, and special appreciation goes to the #AGHE Summit and Partners For Patients NGO for hosting such an important platform. #WEF24

This morning the Centers for Medicare & Medicaid Services announced the maximum fair prices (MFPs) of the first 10 drugs that were negotiated under the #InflationReductionAct. Our #drugpricing and #Medicare experts are looking closely at what this announcement means for #lifesciences firms and #healthplans. Connect with an #AvalereExpert today to discuss: ✔ CMS's rationale and priorities in setting these MFPs ✔ How this announcement impacts #marketaccess ✔ Impacts across #therapeuticareas Connect with us: https://lnkd.in/gx9Z9_3v #IRA #drugpricing #healthpolicy

It cannot be understated how important winning this award was for us here at BeaconMedaes UK. At BeaconMedaes, we are not just suppliers; we are pioneers at the forefront of #medical innovation. For example, our Turnkey #Sustainability Package is not merely a product but a testament to our dedication to aiding the NHS and the broader healthcare market in achieving their net-zero targets. The integration of avant-garde solutions like the Central Destruction Unit (CDU) from Medclair AB and the Halogenated Drug Recovery unit (HDR) from Class 1 Inc. into our sustainability strategies represents the zenith of healthcare innovation, ensuring that environmental stewardship and medical efficiency coalesce seamlessly. Being recognised as the IHEEM 2023 Healthcare Supplier of the Year is not just an accolade for us; it is a clarion call to the industry, highlighting the paramount importance of sustainable healthcare solutions. We are setting benchmarks, not just meeting them, propelling the entire sector towards a future where medical excellence and environmental sustainability are not just aligned but are inextricably linked. This award reaffirmed our unwavering commitment to pioneering a sustainable future in the #NHS. With BeaconMedaes, the future is not just bright; it is sustainable, innovative, and profoundly impactful.

We’re thrilled that our Founder & CEO, Michael Pace, will be moderating this timely HealthXL roundtable this week, w/ host Richard Bunney of Deviceology Ltd. While the sun may have set on some early pioneering prescription #digitaltherapeutics firms, legacies are being leveraged, learnings are being applied and the landscape is shifting in ways like never before, opening up new opportunity for the next generation of #PDT companies. We are very excited about the next phases of integration of #PDTs into standards of care and traditional #pharmacy and #medical benefits in the U.S. #digitalhealth #dtx #digital #health #medicaldevices #healthcare #pharmaceuticals #software #medicine